PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.6101
-0.0132 (-2.12%)
At close: Jul 21, 2026, 4:00 PM EDT
0.6101
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $6.55 million as of July 21, 2026. Its market cap has decreased by -7.75% in one year.
Market Cap
6.55M
Enterprise Value
-14.09M
1-Year Change
-7.75%
Ranking
Category
Stock Price
$0.61
ChartMarket Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $6.55M, a decrease of -61.47%. That is a compound annual growth rate of -6.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 6.55M | -10.28% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
| Jan 2, 2013 | 17.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 7.16M |
| Kairos Pharma | 6.89M |
| Acurx Pharmaceuticals | 6.66M |
| XTL Biopharmaceuticals | 6.47M |
| Xenetic Biosciences | 6.44M |
| Ernexa Therapeutics | 6.33M |
| Evogene | 6.20M |
| Addex Therapeutics | 6.19M |